Daunorubicin hydrochloride

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

471 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	88	156	111	19	23	355
Myeloid leukemia acute	D015470	—	C92.0	77	112	69	4	17	245
Myeloid leukemia	D007951	—	C92	70	98	62	3	12	214
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	13	59	47	14	14	139
Lymphoid leukemia	D007945	—	C91	9	49	36	11	10	108
Lymphoma	D008223	—	C85.9	9	27	14	2	1	49
Philadelphia chromosome	D010677	—	—	2	11	3	2	—	16
Promyelocytic leukemia acute	D015473	—	C92.4	—	4	3	3	1	11

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Myelodysplastic syndromes	D009190	—	D46	15	26	18	—	3	56
Preleukemia	D011289	—	—	11	16	17	—	2	41
Syndrome	D013577	—	—	8	11	13	—	2	31
Non-hodgkin lymphoma	D008228	—	C85.9	4	12	9	—	1	26
Neoplasms	D009369	—	C80	8	9	4	—	2	21
Carcinoma	D002277	—	C80.0	6	5	2	—	—	12
Myeloproliferative disorders	D009196	—	D47.1	3	6	4	—	—	12
Recurrence	D012008	—	—	6	5	1	—	1	11
Neoplasm metastasis	D009362	EFO_0009708	—	3	3	5	—	1	11
Sarcoma	D012509	—	—	4	3	5	—	—	10

Show 59 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Large b-cell lymphoma diffuse	D016403	—	C83.3	6	3	—	—	—	7
B-cell lymphoma	D016393	—	—	5	4	—	—	—	7
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	3	5	—	—	—	6
Hodgkin disease	D006689	—	C81	2	4	—	—	—	6
Blast crisis	D001752	—	—	1	3	—	—	—	4
Urinary bladder neoplasms	D001749	—	C67	—	3	—	—	—	3
Biphenotypic leukemia acute	D015456	—	C95.0	2	1	—	—	1	3
Residual neoplasm	D018365	—	—	—	2	—	—	1	3
Transitional cell carcinoma	D002295	—	—	—	2	—	—	—	2
Primary myelofibrosis	D055728	—	D47.4	2	1	—	—	—	2

Show 28 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Hematologic neoplasms	D019337	—	—	5	—	—	—	—	5
Ovarian neoplasms	D010051	EFO_0003893	C56	3	—	—	—	—	3
Lung neoplasms	D008175	—	C34.90	2	—	—	—	—	2
Fallopian tube neoplasms	D005185	—	—	2	—	—	—	—	2
Burkitt lymphoma	D002051	—	C83.7	2	—	—	—	—	2
Stomach neoplasms	D013274	EFO_0003897	C16	2	—	—	—	—	2
Ovarian epithelial carcinoma	D000077216	—	—	2	—	—	—	—	2
Prostatic neoplasms	D011471	—	C61	1	—	—	—	—	1
Castration-resistant prostatic neoplasms	D064129	—	—	1	—	—	—	—	1
Pancreatic neoplasms	D010190	EFO_0003860	C25	1	—	—	—	—	1

Show 26 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Ataxia	D001259	—	R27.0	—	—	—	—	1	1
Ataxia telangiectasia	D001260	Orphanet_100	G11.3	—	—	—	—	1	1
Telangiectasis	D013684	—	—	—	—	—	—	1	1
Cerebellar ataxia	D002524	—	—	—	—	—	—	1	1
Hiv	D006678	—	O98.7	—	—	—	—	1	1
Cardiomyopathies	D009202	EFO_0000318	I42	—	—	—	—	1	1
Induction chemotherapy	D060828	—	—	—	—	—	—	1	1
Eye abnormalities	D005124	—	Q15.9	—	—	—	—	1	1